Hemocompatible Hydrophilic Coatings for Blood-Contact Medical Devices

Medical devices that come in contact with blood have special challenges. Any surface that comes into contact with blood needs to be designed carefully to reduce problems like blood clotting (thrombosis), damage to blood cells, and inflammation. This is where special coatings called hemocompatible hydrophilic coatings play an important role. These coatings create a biocompatible, protective and lubricious layer on the surface of the device. This layer helps the device’s synthetic materials work better with the body’s blood system.

This article looks into the role, uses, and benefits of hemocompatible hydrophilic medical coatings for blood-contacting medical devices. In addition, we also examine how different curing technologies, UV and thermal cure coatings, influence the coatings’ biological performance. You will want to make sure you read until the end if you are a biomedical engineer that is interested in blood contact medical devices. That is because these coatings can help you improve the safety and effectiveness of your company’s devices. 

Why Hemocompatibility Matters For Blood-Contacting Medical Devices

What is hemocompatibility in terms of medical devices? It describes how well a medical device interacts with blood without causing harmful reactions. 

When a device has poor hemocompatibility, it can lead to:

• Thrombosis (clotting on device surfaces)
• Platelet activation and aggregation
• Hemolysis (red blood cell damage)
• Complement activation and inflammation

When it comes to blood-contacting medical devices hemocompatibility is important. The device’s surface needs to be designed in a way that avoids problems while still allowing the device to function as intended and meets all the regulatory requirements.¹

Role of Hydrophilic Coatings in Hemocompatibility

Hydrophilic coatings help to improve the hemocompatibility of medical devices^2-4 by:

• Lowering protein adsorption, which helps prevent the start of blood clotting
• Reducing friction, which makes it easier to insert or move devices within blood vessels 
• Creating a hydrated layer, which acts like the natural lining of blood vessels
• Stopping platelet adhesion, which prevents platelets from sticking together and activating

Hemocompatible hydrophilic coatings are especially effective on polymers and metals commonly used in blood-contacting medical devices.

Thermal vs. UV Curing Technologies and their Effects on Hemocompatible Coatings ^5,6

Curing technologies are very important in successfully coating a device’s surface. However, the way these materials are cured also changes their surface properties. This includes things like how tightly the molecules are linked together and the coating’s stability. There are two main curing methods that are commonly used for hydrophilic medical coatings: UV curing and thermal curing.

Thermal Curing

What is it? Heat is applied to initiate crosslinking or solvent evaporation. Thermal curing solidifies the coating onto the substrate.

Advantages:

• Heat can reach deeper into materials, helping to cure surfaces that are complex or have thick layers. This is also useful for complex shapes that may not be reached by UV light in some cases. 
• Creates strong chemical structures that can handle being in contact with blood and being sterilized over a long time.
• Usually works well with slow-curing, low-reactivity substances that are used in special medical products.

Disadvantages:

• High temperatures may not be a fit for all materials, as the temperatures can degrade sensitive substrates or biomolecules.
• Longer processing times use more energy and take more time to complete.
• Less control over coating uniformity and repeatability. This may impact surface smoothness and hemocompatibility.

UV Curing

What is it? UV Curing by ultraviolet (UV) light initiates rapid polymerization of photo-reactive groups, curing the coating quickly.

Advantages:

• Allows for quicker curing at lower temperatures. This keeps heat-sensitive materials and medications safe.
• Creates smooth and even coatings. This helps reduce places where platelets can stick or clots can form.
• Provides precise control over the process. It ensures consistent batches and easy tracking.
• It can be adjusted to make surfaces that are highly hydrated and prevent blood clots.

Disadvantages:

• Only works with materials that let UV light pass through or surfaces that are easy to reach.
• There is a chance that some areas may not cure completely, especially in shadows or less accessible spots. This can cause potential issues. 
• It’s important to choose the right photo-initiator carefully to prevent toxicity to cells and to make sure it is safe for biological use.

Learn more about the differences of UV coatings vs thermal coatings and how to choose the right one for your application.

Key Hemocompatibility Testing Methods for Hydrophilic-Coated Medical Devices

To ensure that a hydrophilic coating is truly hemocompatible, it must undergo rigorous testing. These tests focus on interactions between medical devices and blood. These tests are critical for regulatory approval and clinical safety. A good analytical testing partner can help you determine which tests are appropriate and perform them for your product. 

Below are the most commonly used and regulatory-accepted methods for assessing hemocompatibility:^7-12

1. Platelet Adhesion and Activation Assay

Purpose: Evaluates how many platelets adhere to the surface and whether they activate (change shape, release granules), potentially triggering thrombosis.

• Method: Coated substrates are incubated with platelet-rich plasma. Platelet count is measured before and after contact. The surfaces are examined by scanning electron microscopy (SEM) or fluorescent staining.
• Relevance: Activated platelets initiate clotting. Minimal adhesion indicates a non-thrombogenic surface.

2. Coagulation Assays 

Purpose: Coagulation assays testing determines whether the coated surface affects the normal blood coagulation cascade.

• Prothrombin Time (PT): Assesses the extrinsic pathway of blood clotting.
• Activated Partial Thromboplastin Time (aPTT): Measures the intrinsic pathway of blood clotting.
• Thrombin Time: Assesses the final conversion of fibrinogen to fibrin.
• Relevance: Prolonged times may indicate anticoagulant effects; shortened times may suggest pro-thrombotic risk.

3. Complement Activation Assay 

Purpose: Measures whether the device activates the complement system, part of the innate immune system response.

• Method: Blood is incubated with the test sample, and complement system activation markers (C3a, C5a, SC5b-9) are quantified via ELISA.
• Relevance: Complement activation can trigger inflammation, allergic-like responses, or systemic immune complications.

4. Clot Weight or Thrombus Formation Assay 

Purpose: Directly assesses the formation of clots on the surface of the coated material.

• Method: Devices are exposed to whole blood for a fixed period. The clots are removed, dried, and weighed.
• Relevance: A lower clot weight indicates a more hemocompatible and less thrombogenic (thromboresistant) surface.

5. In Vitro Flow Loop Models 

Purpose: Simulates blood flow over the coated surface under dynamic conditions.

• Method: The coated device is placed in a closed-loop system with recirculating blood. Hemolysis, clotting, and platelet activity are monitored over time.
• Relevance: Provides a more physiologically relevant evaluation of real-time blood compatibility under shear stress.

Blood-Contacting Devices That Benefit from Hemocompatible Hydrophilic Coatings

Hydrophilic hemocompatible coatings play an important role in blood-contacting medical devices. They help prevent blood clots, reducing complications and making patients more comfortable. Hemocompatible hydrophilic coatings also help improve the success of medical procedures. 

Here are some key examples of devices commonly using these surface coatings:

1. Central Venous Catheters (CVCs) ^3,13

A Central Venous Catheter (CVC) is a thin, flexible tube that is placed into a large vein, often located in the neck, chest, or groin area. This device allows healthcare providers to easily give medications, fluids, blood products, and nutrition to patients. It is also used for monitoring blood pressure and drawing blood samples. 

Hemocompatible hydrophilic coating provide the following benefits in Central Venous Catheter (CVC)’s:

• Lubricious coatings help in reducing friction during insertion of the catheter into central veins 
• Minimizing protein adhesion and clot formation on the catheter surface, improving patency.
• Lowering the risk of catheter-related thrombosis.
• Enhances patient comfort and reduces inflammation during extended use.

Learn more about Hydrophilic Catheter Coatings and their benefits. 

2. Hemodialysis Circuits ¹⁴

Hemodialysis circuits mainly consist of bloodlines and dialyzers: 

• Bloodlines: These are tubes that transport the patient’s blood to and from the dialyzer.
• Dialyzer: This device, often called an artificial kidney, filters the blood to clean it.

Together, these components help keep patients healthy when their kidneys are not functioning properly. 

Hemocompatible hydrophilic coating helps hemodialysis circuits by:

• Preventing platelet adhesion and fibrin formation during long-term blood contact.
• Reducing biofouling of dialyzer membranes, improving performance, and reducing filter replacement frequency.
• Enhancing biocompatibility of tubing and pump chambers, lowering the risk of clotting and immune reactions.

3. Guidewires ¹⁵

Coronary and peripheral guidewires are thin, flexible wires. They are used in minimally invasive procedures to navigate and access blood vessels. Guidewires allow for the placement of other medical devices like catheters and stents. 

Hydrophilic coating are beneficial for use on guidewires because they:

• Provide lubricity for smooth vascular navigation, even through tortuous anatomy.
• Prevent micro-damage to the endothelium, which can trigger clotting or inflammation.
• Help avoid device entrapment or vasospasm by reducing surface resistance.

Learn more about the benefits of hydrophilic guidewires coatings. 

4. Drug-Eluting Stents and Vascular Stents ^16,17

A drug-eluting stent (DES) is a small, mesh-like tube, typically made of metal. These stents are inserted into a narrowed or blocked artery to improve blood flow. Stents contain drugs that are locally released to prevent the re-narrowing of the artery. 

Modifying drug-eluting stents with hemocompatible hydrophilic coating helps in:

• Reducing early thrombus formation during endothelialization.
• Promoting a passivated, lubricious surface during deployment and anchoring.
• Ensuring smooth, non-traumatic delivery through vascular structures.
• Maintaining a non-thrombogenic interface to preserve drug delivery performance.
• Supporting controlled hydration that can optimize drug release profiles.

Hydromer® Hemocompatible Hydrophilic Coatings

Hydromer® thromboresistant coatings are advanced, hydrophilic surface treatments designed to reduce the risk of blood clot formation on medical devices. These hydrophilic hemocompatible coatings create a slippery-when-wet, non-reactive surface that resists platelet adhesion and activation. The coatings’ thromboresistant performance makes them ideal for blood-contacting devices like catheters, stents, and vascular grafts. Their use improves patient safety and enhances device performance and longevity. 

All Hydromer coatings can be customized to meet your specific product requirements. 

In addition, our company provides a wide range of support services. These range from analytical testing, contract R&D, contract coating services, custom equipment development, regulatory consulting, and technology transfer.

Contact us today to ask a coatings expert questions or to start your custom coatings project. 

Conclusion

There is a need for safer and more effective blood-coating medical devices. Hemocompatible hydrophilic coatings are important in terms of making these devices work well with the body. Both, thermal and UV curing methods are reliable coating techniques. The key is to choose both the right coating formulation and coating method to meet your product requirements. Hydromer makes special hemocompatible coatings that are designed for blood-contacting medical devices. Our coatings use both UV light and heat cure methods.

References

Click to view the references for this article.

1. Goud N. Biocompatibility evaluation of medical devices. A comprehensive guide to toxicology in nonclinical drug development. Elsevier; 2024:957-973.

2. Fischer M, Maitz MF, Werner C. Coatings for biomaterials to improve hemocompatibility. Hemocompatibility of biomaterials for clinical applications. Elsevier; 2018:163-190.

3. Liu C, Lin Z, Qiao C, et al. Hemocompatibility assay of a micro-catheter using hydrophilic coating biomaterials. Bio-medical materials and engineering. 2019;30(1):1-9. 

4. Obiweluozor FO, Tiwari AP, Lee JH, et al. Thromboresistant semi-IPN hydrogel coating: towards improvement of the hemocompatibility/biocompatibility of metallic stent implants. Materials Science and Engineering: C. 2019;99:1274-1288. 

5. Incure. UV Curing vs. Thermal Curing: A Comprehensive Guide. Incure. https://incurelab.com/wp/whats-the-difference-between-led-uv-curing-and-thermal-curing#:~:text=Thermal%20Curing:%20The%20Heat%20Method,customization%20of%20the%20material’s%20properties.

6. Paradowska A, Kaźmierska K, Ciach T. Influence of the coating process parameters on the quality of PUR/PVP hydrogel coatings for PVC medical devices. Polish Journal of Chemical Technology. 2010;12(2):38-45. 

7. Nalezinková M. In vitro hemocompatibility testing of medical devices. Thrombosis Research. 2020/11/01/ 2020;195:146-150. doi:https://doi.org/10.1016/j.thromres.2020.07.027

8. Hong JK, Gao L, Singh J, et al. Evaluating medical device and material thrombosis under flow: current and emerging technologies. Biomaterials Science. 2020;8(21):5824-5845. 

9. Jamiolkowski MA, Hartung MC, Malinauskas RA, Lu Q. An in vitro blood flow loop system for evaluating the thrombogenicity of medical devices and biomaterials. ASAIO journal. 2020;66(2):183-189. 

10. Timms DL, Gregory SD, Greatrex NA, Pearcy MJ, Fraser JF, Steinseifer U. A compact mock circulation loop for the in vitro testing of cardiovascular devices. Artificial organs. 2011;35(4):384-391. 

11. De Jong WH, Carraway JW, Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and performance of medical devices. Elsevier; 2020:123-166.

12. ISO. Biological evaluation of medical device. International Standard Organization. 2017;

13. Thorarinsdottir H, Kander T, Johansson D, Nilsson B, Klarin B, Sanchez J. Blood compatibility of widely used central venous catheters; an experimental study. Scientific Reports. 2022;12(1):8600. 

14. Liu Y, Li G, Han Q, et al. Anticoagulant dialyzer with enhanced Ca2+ chelation and hydrophilicity for heparin free hemodialysis. Journal of Membrane Science. 2020;604:118082. 

15. Edwards PA, Price M, Nimchuk N, Mahon J. Novel Water Loving Coatings (WLC) Lubricious and Durable Guidewires. 2017; Accessed 2/1/2025. https://doi.org/10.1115/DMD2017-3434 2017 Design of Medical Devices Conference

16. Zawidlak-Węgrzyńska B, Rydz J, Musioł M, Radziwon-Balicka A. Polymer-Drug Anti-Thrombogenic and Hemocompatible Coatings as Surface Modifications. Pharmaceutics. 2024;16(3):432. 

17. Udriște AS, Burdușel AC, Niculescu A-G, Rădulescu M, Grumezescu AM. Coatings for Cardiovascular Stents—An Up-to-Date Review. International Journal of Molecular Sciences. 2024;25(2). doi:10.3390/ijms25021078